Neoplasms of the Pancreatic Body and Tail, Incidence in University Clinical Centre of Kosova
[1]
Dedushi Kreshnike, Department of Radiology, Diagnostic Centre, UCCK, Prishtina City, Kosova; Faculty of Medicine, Prishtina University, Prishtina, Kosova.
[2]
Kabashi Serbeze, Department of Radiology, Diagnostic Centre, UCCK, Prishtina City, Kosova; Faculty of Medicine, Prishtina University, Prishtina, Kosova.
[3]
Ahmetgjekaj Ilir, Department of Radiology, Diagnostic Centre, UCCK, Prishtina City, Kosova; Faculty of Medicine, Prishtina University, Prishtina, Kosova.
[4]
Hoxhaj Astrit, Hospita Hygea, Tirane City, Albania.
[5]
Hasbahta Gazmend, Faculty of Medicine, Prishtina University, Prishtina, Kosova.
[6]
Biçaku Ardian, Department of Radiology, Diagnostic Centre, UCCK, Prishtina City, Kosova; Faculty of Medicine, Prishtina University, Prishtina, Kosova.
[7]
Kabashi Antigona, Department of Radiology, Diagnostic Centre, UCCK, Prishtina City, Kosova; Faculty of Medicine, Prishtina University, Prishtina, Kosova.
[8]
Muçaj Sefedin, Faculty of Medicine, Prishtina University, Prishtina, Kosova.
Aim of the paper: The object of this paper is the incidence of the pancreatic body and tail cancers among the total cases of the pancreatic cancers diagnosed in the University Clinical Center of Kosova, with the aim to compare these research findings to similar studies made in the developed countries. This is a retrospective research study done during the period of 2012-2014. Materials and Methodology: This retrospective research study includes 72 patients diagnosed with pancreatic cancer, examined in the period of 2012-2014 in the University Clinical Center of Kosova. The imaging diagnostics are performed with MSCT Sensation 64 Siemens, MSCT Emotion 6 Siemens, and 1.5T MRI Symphony Siemens, in the Radiologic Clinic of UCCK; while the histopathologic diagnostics has been performed in the Pathologic Clinic of UCCK. Results: Out of a total of the 72 patients diagnosed with pancreas cancer, 9 cases resulted in body and tail cancers (12.5%). Discussion and Conclusions: Compared to studies made in the developed countries (approximately 25% of cases), the percentage found in this study is significantly smaller (12.5%). From an imaging point of view, these cancers were presented in an advanced stage, mainly due to their late clinical symptomatology, compared to pancreatic head and neck cancers.
Incidence of the Pancreatic Body and Tail Cancers, MSCT, MRI, University Clinical Center of Kosova, Prishtine, Kosova
[1]
Zamboni G, Scarpa A, Bogina G, Iacono C, Bassi C, Talamini G, Sessa F, et al. Mucinous cystic tumors of the pancreas: clinic pathological features, prognosis, and relationship to other mucinous cystic tumors. Am J SurgPathol 1999;23(4):410-422.
[2]
Goh BK, Tan YM, Cheow PC, Chung YF, Chow PK, Wong WK, Ooi LL. Cystic neoplasms of the pancreas with mucin-production. Eur J SurgOncol 2005;31(3):282-287.
[3]
Adsay NV, Longnecker DS, Klimstra DS. Pancreatic tumors with cystic dilatation of the ducts: intraductal papillary mucinous neoplasms and intraductaloncocytic papillary neoplasms. SeminDiagnPathol 2000;17(1):16-30.
[4]
Nakamura A, Horinouchi M, Goto M, Nagata K, Sakoda K, Takao S, Imai K, et al. New classification of pancreatic intraductal papillary-mucinous tumour by mucin expression: its relationship with potential for malignancy. J Pathol 2002;197(2):201-210.
[5]
Adsay NV, Conlon KC, Zee SY, Brennan MF, Klimstra DS. Intraductal papillary-mucinous neoplasms of the pancreas: an analysis of in situ and invasive carcinomas in 28 patients. Cancer 2002;94(1):62-77.
[6]
Furukawa T, Kloppel G, VolkanAdsay N, Albores Saavedra J, Fukushima N, Horii A, Hruban RH, et al. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch 2005;447(5):794-799.
[7]
Beauchamp RD, Thompson JC. Endocrine tumors of the pancreas. In: Zinner MJ, Schwartz SI, Ellis H, editors. Maingot’s Abdominal Operations. 10th edn.Appleton and Lange; 1997.pp1961-1976.
[8]
G. McAuley, H. Delaney, J. Colville, I. Lyburn, D. Worsley, P. Govender, W.C. Multimodality preoperative imaging of pancreatic insulinomas. Clinical Radiology, October 2005 Volume 60, Issue 10, Pages 1039–1050.
[9]
Jeffrey A. Norton, MD. Surgical treatment and prognosis of gastrinoma. Best Practice & Research Clinical; Gastroenterology, October 2005 Volume 19, Issue 5, Pages 799–805.
[10]
Shoup M, Conlon KC, Klimstra D, Brennan MF. Is extended resection for adenocarcinoma of the body or tail of the pancreas justified? J GastrointestSurg 2003;7(8):946-952; discussion 952.
[11]
Christein JD, Kendrick ML, Iqbal CW, Nagorney DM, Farnell MB. Distal pancreatectomy for resectable adenocarcinoma of the body and tail of the pancreas. J GastrointestSurg 2005;9(7):922-927.
[12]
Yang MJ, Li S, Liu YG, Jiao N, Gong JS. Common and unusual CT and MRI manifestations of pancreatic adenocarcinoma: a pictorial review. Quant Imaging Med Surg. 2013 Apr;3(2):113-20. doi: 10.3978/j.issn.2223-4292.2013.04.02.
